NASDAQ:AIP

Arteris (NASDAQ:AIP) Insider Sales: Executives Offload Shares Amid Strong Financial Performance in AI and Data Center Market

Font: Financial Modeling Prep  • May 16, 2026

Market Chart
  • Despite robust financial results, Arteris, Inc. (NASDAQ:AIP) has experienced significant insider stock sales from its CFO and a Director.
  • The company reported strong Q1 revenue growth of 39%, reaching $22.94 million, and a reduced adjusted loss of $0.03 per share, outperforming analyst expectations.
  • Positive financial momentum is further evidenced by a 39% increase in annual contract value and a 33% rise in remaining performance obligations, signaling a strong future business pipeline.

Arteris, Inc. (NASDAQ:AIP) provides key technology for designing complex computer chips used in AI and data centers. The company's activities focus on system-on-chip (SoC) architectures that are vital for modern electronics. Recently, the company has seen significant insider stock sales, including a large transaction by its Chief Financial Officer, Hawkins Nicholas B.

On May 15, 2026, the CFO sold 52,928 shares of AIP common stock. The shares were sold at a price of $32.97 each, making the total transaction value approximately $1.75 million. After this sale, Hawkins Nicholas B. continues to hold 278,707 shares in the company, with the transaction filed on May 16, 2026.

This insider sale comes at a time of strong financial performance for Arteris. As highlighted by Benzinga, the company's first-quarter revenue was $22.94 million, a 39% increase from the previous year that beat analyst estimates. AIP also reported a smaller adjusted loss of $0.03 per share, which was better than the expected loss of $0.07.

Other financial metrics also show positive momentum. The company’s annual contract value plus royalties increased by 39% year-over-year to $92.80 million. Furthermore, remaining performance obligations, which represent future revenue from existing contracts, grew by 33% to $118.30 million, indicating a strong pipeline of future business.

The CFO's sale is not an isolated event. As highlighted by The Motley Fool, Director Antonio J Viana also sold 20,000 shares for about $601,000.00. This pattern of executive selling continues even as the company reports record financial results and sees its stock price fluctuate, with a recent daily drop of 9.72%.

Market Overview
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.83
-7.29%
SLXN
Silexion Therapeutics Ltd.
$0.53
96.95%
HAO
Haoxi Health Technology Limited
$0.01
0.71%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.54
-14.00%
MEHA
Functional Brands, Inc. Common Stock
$0.09
21.95%
JUNS
Jupiter Neurosciences, Inc.
$0.21
-35.94%
PHGE
BiomX Inc.
$0.60
59.60%
WOK
WORK Medical Technology Group Ltd.
$0.19
-19.57%
HCWB
HCW Biologics Inc.
$2.43
129.25%
GDC
GD Culture Group Limited
$0.12
-17.44%